StockData
CERo Therapeutics Holdings, Inc. logo

CERo Therapeutics Holdings, Inc. (CERO) stock

CEROOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CEROW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.01+0.00 (0.00%)

Close on Oct 19, 2026Market cap $253.05KP/E –Yield 172833.33%

CERo Therapeutics operating margin

Operating margin is operating income as a percentage of revenue.

No operating margin figures for CERo Therapeutics

CERo Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More CERo Therapeutics figures

See a number that looks wrong?